TESTIMONY. Covid-19: Barrier Barrier for Novavax Candidates Still Hard to Reach

essential
Some vaccine candidates are abandoning products that use so-called RNA information technology. Arriving in France in February, Nuvaxovid, a recombinant protein vaccine, had to shuffle the cards. However, in the field, access to this vaccine remains difficult for many patients.

According to her, she passed a real “obstacle course”. 70-year-old Brigitte * was looking forward to the Nuvaxovid vaccine (from the American Novavax laboratory). Pfizer, Moderna… This Saint-Germain resident in Tarn doesn’t want that. She refuses any vaccine that works with messenger RNA. “I’ve been battling shingles for almost 17 years, and I suspect it’s a technology to reactivate the disease,” explains the seven-year-old.

Read also:
Covid-19: where can Novavax vaccination be given in France?

Therefore, Bridget was looking forward to the release of new recombinant protein vaccines: a more traditional technology, which is the introduction of a protein specific for the virus (Spike protein) in the cells of the body to stimulate the immune system. The first protein vaccine arrived in France only in late February: “Unfortunately, the first doses were distributed as a priority in overseas departments refractory to RNA vaccines to encourage the population to be vaccinated,” says Brigitte.

Is there no vaccine in pharmacies?

Tarnes is patient with his problems and makes an appointment on March 12 at one of the five vaccination centers to receive the first dose. In a few days, the vaccination centers take turns closing their doors. His friend, Brigitte, is trying to get it from a pharmacist: “Nobody offered Novavax,” Tarnes said. Therefore, the protein vaccine is not available in pharmacies?

Read also:
Covid-19 vaccines: can a person under the age of 60 be revaccinated in France?

“We have too few requests for this vaccine,” explains Philippe Besse, president of the Federation of Pharmaceutical Unions of France (FSPF), at La Dépêche du Midi. “If we open a vial of 10 doses of vaccine for one person, we throw out nine. It’s annoying, and it can cost society dearly, ”continues the pharmacist who works in Lima (Od). On April 8, after she was forced to cancel a series of meetings, Brigitte was finally invited to the only vaccination center still operating in Tarna, 60 kilometers from her home. “I regret the lack of communication on the closure of vaccination centers and these new vaccines,” said the seven-year-old.

This is not the end of his obstacle course. In a few months, Tarnes will need a booster injection. The problem is that only vaccines that use RNA technology are allowed as a “third dose”: “If I have to get a revaccination in the next few months, I will still get a recombinant protein vaccine,” says Brigitte. I haven’t waited so many months to finally give up the vaccine I’m giving up. »

Read also:
SERVICE. Vaccines against Covid-19: “We must at least provide a new reminder for the most fragile,” said Fischer

For his part, the president of the Strategic Orienteering Council said that Novavax still had to provide a number of documents proving the effectiveness of its vaccine in the context of vaccine withdrawal: “This should be done in the coming weeks. “- says the professor.

Where to get vaccinated with Nuvaxovid?

Nuvaxovid, without messenger RNA, is the fifth vaccine to be approved in France. The Novavax vaccine is available at several vaccination centers in mainland France. Occitania has already ordered almost 42,000 doses and it is possible to receive injections in various hospitals and vaccination centers in the region’s metropolises, according to Oksitania’s URPS. In the city, you should contact your healthcare provider directly to find out if you can order this vaccine.